Enlarged Prostate
An enlarged prostate, also called benign prostatic hyperplasia (BPH), is common in older men. The prostate is a walnut-sized gland that surrounds the urethra. It starts at the base of the bladder and runs through the middle of the prostate. Over time, an enlarged prostate can stop or slow urine flow, causing bladder and kidney problems.
As men age, the prostate grows. Sometimes, it can grow into the urethra, making the opening narrower. As a result, the bladder has to work harder to get urine out when this happens. Unfortunately, the bladder becomes more irritable when it works harder — meaning it will not tolerate holding urine well.
At City of Hope, we use several methods to diagnose an enlarged prostate. These include symptom score sheets, flow rate tests, postvoid residual measurement, cystoscopy, prostate volume measurements, prostate-specific antigen tests, and urine culture.
Working together with your urologist, you can determine a personalized treatment plan based on your preferences, prostate size and overall health.
Additional information about the prostate, treatments and health maintenance
City of Hope is a nationally recognized leader in researching and treating urologic cancers and has been named by U.S. News & World Report as one of America's top urology and cancer hospitals.
Just as no two patients are alike, an enlarged prostate requires a personalized treatment plan to obtain the best possible outcomes. City of Hope's renowned physicians and researchers utilize the latest technology and innovation to treat urologic conditions, coupled with our enduring belief in providing unparalleled compassionate care.
As a founding member of the National Comprehensive Cancer Network, our doctors also help develop and improve evidence-based prostate cancer treatment guidelines for patients throughout the country.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
